real-time news and commentary for investors
Monday, Nov 12
2012, 5:15 PM
Sequenom (SQNM) says it's achieved positive results from a study of its RetnaGene AMD...
Sequenom (SQNM) says it's achieved positive results from a study of its RetnaGene AMD laboratory-developed test, which is designed to accurately predict the risk of disease progression of age-related macular degeneration. The announcement was made during its presentation today at the 2012 Joint Meeting of the American Academy of Ophthalmology and the Asia-Pacific Academy of Ophthalmology in Chicago. Shares +0.3% AH.